Current Drug Delivery

Dr. Isabella Macario F. Cavalcanti is presently working as Professor at the Academic Center of Vitoria at the Federal University of Pernambuco (CAV/UFPE), Brazil. She has completed her Ph.D. in Biological Sciences from the Laboratory of Immunopathology Keizo Asami (LIKA) at the Federal University of Pernambuco (UFPE), Brazil. She has been awarded a Certificate of outstanding contribution in reviewing the manuscripts of the Industrial Crops and Products, Elsevier. She has published around 30 articles in different journals and more than 8 books.

Professor Munish Garg is presently working as Dean, Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India. He has 20 years of experience in academic and research. His research areas involve quality control and standardization of medicinal plants, development of novel drug delivery formulations using phytochemicals for enhanced therapeutic profile and bio-prospecting aspects of medicinal plants for socio-economic development. He has published more than 60 publications in reputed journals, 5 patents in progress, 3 published books and several book chapters published. He has secured financial grants of more than 15 million INR from government agencies. He is a member of several financial grant awarding agencies to screen research projects.

Dr. Luigi Laino is a graduate in Medicine and Surgery and Specialized in Dermatology and Venereology from La Sapienza, University of Rome. He contributed numerous scientific publications in international journals and author of chapters of scientific books. He is currently the Editor of 5 international scientific journals. He has published important scientific research on Lichen sclerosus and Alopecia Areata. He is an expert in Dermoscopy, Dermosurgery, and Dermoncology.

Dr. Jing-an Li is a professor of Zhengzhou University, China, and his research filed include: Drug delivery and biomaterials. So far, he has published more than 40 academic papers on international academic journals as the first author or corresponding author, including ACS Applied Materials & Interface, Applied Surface Science, Biomaterials Science, and Journal of Materials Chemistry B. He has been serving as the editorial board member of repute journals, such as Current Chinese Biotechnology (Section Editor), Recent Patents on Nanotechnology, Biomed Research International (Lead Guest Editor), Genetics and Molecular Research, Current Drug Delivery (Executive Guest Editor). He was also honored with repute awards, such as “China-Korea Young Scientist Award”, “IAAM Scientist Award”, “IAAM Medal”, and “Outstanding Reviewer Award” of repute journals.

Dr. Zhepeng Liu obtained Ph.D. from the University of Fudan, in the field of pharmacy. Dr. Liu is working at the School of Medical Instrument and Food Engineering, the University of Shanghai for Science and Technology. His research areas focus on the new drug dosage forms and new technologies, mainly involving: 1) Drug formulations such as liposome, nanoparticle, nanocrystalline; 2) Formulations technology such as electrospray, electrospinning, microfluidics; and 3) Exploring accurate and orderly controlled release of drugs and the combination therapy in treating tumors.

Dr. Giuseppe Minervini received his degree in Dentistry at the University of Campania, Luigi Vanvitelli, Naples, Italy. Currently, he is an Orthodontics Dentistry Postgraduate and Ph.D. attending in Biochemistry and Biotechnology at the University of Campania, Luigi Vanvitelli, Naples, Italy. His research interests regard biomedical and biomaterials application for craniofacial, oral, and temporomandibular districts. He published several articles in ISI-indexed Journals with impact factors.

Dr. Maha Nasr is an Associate Professor of Pharmaceutics, Faculty of Pharmacy, Ain Shams University. Her research is focused on the use of nanoparticles for the treatment of several diseases. She is currently representing Egypt in international academies such as the Global young academy (GYA) and the Arab German young academy (AGYA). She has published 62 articles and is currently among the Editorial Board of 10 international journals and is a reviewer in 71 international journals.

Dr. Chunlin Ou is working in the Department of Pathology, Xiangya Hospital, Central South University. His researches focus on the molecular targeted therapy for human cancers, which mainly involves: 1) The role of Hippo/YAP signaling pathway in targeted therapy of cancers; 2) Exploring the regulatory mechanism of non-coding RNAs in cancers; 3) Searching the novel biomarkers and drug targets for the early diagnosis and therapy of cancers; 4) Clinical implication of mRNA vaccine in cancers. He has published 34 scientific articles in well-known SCI-indexed journals.

Letizia Perillo is a full professor and dean of the School of Dentistry, chairman of the NEBEOP Postgraduate Orthodontic Program, and head of the Orthodontic Division, at the Multidisciplinary Department of Medical-Surgical and Dental Specialties of the University of Campania Luigi Vanvitelli, Naples (Italy). She is a visiting professor at the University of Alabama (USA) and at the University of Alexandria (Egypt). She was the elected president of the Italian Society of Orthodontics (SIDO), and member of the WFO, AAO, EHASO, EOS, SIDO and CH Tweed Foundation. She is an editorial board member of several journals. Prof Letizia Perillo graduated in Medicine and Surgery in 1986 and specialized in Orthodontics in 1989 from the University of Naples Federico II. She completed her orthodontic training with a postgraduate fellowship from the University of Michigan in 1993 and a Ph.D. in Interceptive Orthodontics from the University of Florence in 1997. She is the author and co-author of several scientific publications, 9 books and 10 chapters of books, speaker at national and international courses and congresses.

Dr. Maria Abdul Ghafoor Raja received his Ph.D. in Pharmacy from the Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia. Currently, she is an Assistant Professor at the Department of Pharmaceutics, Faculty of Pharmacy, Northern Border University, Rafha, Saudi Arabia. Her research interests include Liposomes, Nanoparticles, Gene delivery, Drug delivery, and novel targeting, Cell culture, 3D cell culture, Anticancer Drug Resistance, and Tumor targeted drug delivery. She has published several articles in ISI-indexed Journals with impact factor.

Seyed Jamal Tabatabaei Rezaei received his PhD in 2012 from Shahid Beheshti University, Iran and was a postdoc researcher from 2012 to 2013 at Shahid Beheshti University. At present, he is an Associate Professor at Zanjan University, Iran and specializes in biomaterial and nanomedicine, especially the development of targeted drug delivery systems for cancer therapy. The research ranges from design and synthesis of novel polymeric carriers to mechanistic understanding of delivery barriers and to in vivo studies of relevant tumor models. He has published more than 50 academic papers on international academic journals as the first author or corresponding author, including Polymer, Polymer Chemistry, International journal of pharmaceutics, Journal of colloid and interface science, RSC advances, etc.

Dr. Ayhan SAVASER graduated from Hacettepe University Faculty of Pharmacy in 1988, He received his M.Sc. degree in Pharmaceutical Technology with his thesis on ‘The Studies iNH tablets available on the Turkish drug market’’ in Gulhane Mİlitary Medical Academy. He obtained his Ph.D. degree with ‘‘The Development, in vitro evaluation and bioequivalence of sustained release tablet formulations of diclofenac sodium’’ thesis from the same Academy in 1999. He worked as assistant professor between 2000-2006 and received his Associate Professor title in 2007 and Professor title in 2017. He is currently doing his research work at the Department of Pharmaceutical Technology, University of Health Sciences, Gulhane Campus, Ankara. Dr. SAVASER served as BA/BE Evaluation Commission member since 2011 and is the writer of 40 scientific articles, 6 book chapters.

Dr. Faiyaz Shakeel received a Master degree (M. Pharm) and a PhD in Pharmaceutics from Jamia Hamdard (Hamdard University, New Delhi, India). At Jamia Hamdard. In 2011, he was awarded Young Scientist Award from the Association of Pharmacy Professionals (APP). In March 2016, he has been promoted to Associate Professor at King Saud University. He also had very good expertise in solubilization of drug molecules using cosolvency models. His research interest lies in the general area of Pharmaceutics and more recently in the development of nanoemulsions and self-nanoemulsifying formulations for therapeutic applications. He is author of over 180 journal articles and book chapter.

Dr M. Skwarczynski received a Master degree in biotechnology and a PhD in chemistry from Wroclaw University of Technology (Poland). In 2004 he was awarded Japan Society for the Promotion of Science Postdoctoral Fellowship, and a grant to conduct research on paclitaxel.His research interest lies in the general area of medicinal chemistry and more recently in the development of nanomaterials for biomedical applications, vaccine delivery strategies, including design, chemoselective synthesis, conformational studies, and immunological properties of lipopeptide and polymer assembled multivalent vaccine candidates. He is author of over 70 journal articles and book chapters.